- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05939206
rTARUP: Long-term Analysis (rTARUP FU)
rTARUP (Robotic-assisted Transabdominal Retromuscular Umbilical Prosthetic Repair): Long-term Analysis of More Than 48 Months
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The rTARUP technique (robotic assisted transabdominal retromuscular umbilical prosthetic repair) has been introduced in the latest years for the treatment of ventral/umbilical hernias. Short-term analyses have proven that this technique can be performed safely and without complications. The technique maintains the benefits of a traditional laparoscopic approach (smaller incision, faster recovery, shorter hospital stay) and obeys mesh complications related to intraperitoneal mesh placement (adhesions, pain due to mesh fixation). An initial evaluation was conducted at our center to assess recurrence and complications 1 year after the procedure in a patient group of 203 patients. We documented 3 patients with a recurrence of which 2 of them had a laparoscopic intra-peritoneal hernia repair to treat the recurrence. Due to Covid-19 restrictions a clinical follow-up was only possible in 73% of patients. Therefore, we believe that a longer follow-up period of at least 48 months after surgery is necessary and surgically relevant to analyze the primary (recurrence rate) and secondary (long-term complications) end points of the recently introduced rTARUP technique for the treatment of ventral/umbilical hernias.
Muysoms, F., et al., Robotic transabdominal retromuscular umbilical prosthetic hernia repair (TARUP): observational study on the operative time during the learning curve. Hernia, 2018. 22(6): p. 1101-1111.
Muysoms, F., et al., Observational study with one year follow-up on robotic assisted retro-rectus ventral hernia repair (RTARUP) with a self-fixating mesh. Br J Surg, 2021. 108(Suppl 8).
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Gent, Belgium, 9000
- AZ Maria Middelares
-
Ghent, Belgium, 9000
- AZ Maria Middelares
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients that underwent rTARUP procedure in the period September 2016 - December 2019
- Lateral approach to the retromuscular plane/lateral single docking
- Use of Progrip self-fixating mesh
Exclusion Criteria:
- Ventral hernia on the lateral side or combined hernia (lateral and medial)
- eTEP approach to the retromuscular plane
- Use of any other mesh than Progrip self-fixating mesh.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hernia recurrence
Time Frame: After at least 48 months post-operative
|
Hernia recurrence
|
After at least 48 months post-operative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Long-term complications
Time Frame: After 48 months post-operative
|
Long-term complications
|
After 48 months post-operative
|
|
Quality of Life Questionnaire
Time Frame: After 48 months post-operative
|
Minimum score is 0, maximum score is 90.
The higher the score, the worse the outcome
|
After 48 months post-operative
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- rTARUP FU
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Umbilical Hernia
-
Anchora MedicalCompletedPrimary Umbilical HerniaIsrael, Slovenia
-
University Hospital, GhentJohnson & JohnsonCompletedUmbilical Hernias | Ventral HerniasBelgium
-
Tanta UniversityCompletedPostoperative Analgesia | External Oblique and Rectus Abdominis Plane | Umbilical Hernia RepairEgypt
-
Zealand University HospitalBispebjerg Hospital; University Hospital, Gentofte, CopenhagenCompletedInguinal Hernia | Incisional Hernia | Umbilical HerniasDenmark
-
Hvidovre University HospitalNot yet recruitingCirrhosis, Umbilical Hernia
-
University of California, San DiegoUnknownVentral Hernia | Umbilical HerniaUnited States
-
Wake Forest University Health SciencesWithdrawnUmbilical HerniaUnited States
-
Nationwide Children's HospitalTerminated
-
South Shore HospitalQ-Med Scandinavia, Inc.Terminated
-
Children's Hospital of PhiladelphiaChildren's Anesthesiology Associates, Ltd.Completed
Clinical Trials on rTARUP
-
Filip MuysomsCompleted